You haven't searched anything yet.
Principal Scientist/Associate Director, Translational and Biomarker Research
Immunitas: the human approach to oncology
We are developing targeted therapeutics for patients with challenging, complex cancers. We employ
a single-cell sequencing platform to dissect the biology of immune cells in human tumors and
identify exciting, novel oncology targets. We are currently advancing multiple programs toward early
human clinical studies.
We are a small, vibrant team looking for researchers who:
Position Summary
Immunitas is seeking a highly skilled and engaged scientist with leadership experience and expertise
in translational and biomarker research, preferably with immunotherapy experience, to join our
growing team. This individual will help shape and execute the translational and biomarker strategy
across the preclinical and clinical portfolio. The successful candidate will guide translational and
biomarker studies to confirm/generate mechanistic insights and demonstrate target engagement/PD
effects of Immunitas therapeutic agents. He/She will ideally have proven success in building strong
translational data packages supporting INDs, defining biomarker strategies for preclinical/clinical
candidate stage programs, and implementing translational and biomarker programs in clinical trials.
Responsibilities will include:
Biology and Pharmacology, Computational Biology, Molecular Biology and Protein Science,
Antibody Discovery, and Clinical Development
Requirements:
immunology/immuno-oncology, using multiple orthogonal techniques and human tissues
such as blood and tumor tissue samples
into translational and biomarker research
About Immunitas
Immunitas was founded in 2019 by a team of world-class academic scientists who are harnessing
significant advancements in the field of single-cell genomics and computational biology to unlock
novel targets in human immunology. Our start-up team is collaborative and scientifically rigorous.
We’re excited to be working on cutting edge science. We are based in Waltham, MA. We offer
competitive compensation, equity, healthcare, and other benefits.
The founding scientific team is led by Kai Wucherpfennig, M.D, Ph.D. (Dana-Farber Cancer Institute
and Harvard Medical School), and includes Aviv Regev, Ph.D. (Broad Institute), Dane Wittrup, Ph.D.
(MIT) and Mario Suva, M.D., Ph.D. (Massachusetts General Hospital/Harvard Medical School).
To Apply:
Please send resume and brief introduction paragraph to info@immunitastx.com. This employer
participates in E-Verify
Full Time
Scientific Services
$135k-169k (estimate)
04/21/2023
06/05/2024
immunitastx.com
RICHMOND, VA
<25
2018
Private
ROGER M LORIA
<$5M
Scientific Services
Immunitas Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes novel therapies for the treatment of cancer.